Sunday, September 29, 2019
라니티딘
Pharmaceutical industry suffered from ranitidinebr[Economy review]brbrRanitidine medicine discontinued ... Replacement?brAccording to the industry on the 28th, pamotidine is the most potent ingredient in the general medicine as in the alternative to the ranitidine formulation.brbr[Pharmaceutical Bio Biomolecular Week] Carcinogens ...brDrugs made from ranitidine ingredients, which have raised concerns about carcinogens, such as gastrointestinal residues, have been discontinued.brbr[CTV] Ranitidine Carcinogen Detected 334 Timesbr[CBC News ㅣ CBC News] In the gastrointestinal ranitidine, NDMA is estimated to be up to 334 times higher than the baseline.brbr[Pharmaceutical / Bio] Carcinogens, More? ...br[Sun Seoul | Report by Lee Beom-hee] All the products of the gastrointestinal ranitidine ingredient were discontinued due to the detection of carcinogen NDMA (N-nitrosodimethylamine).brbrGeochang Encourages Exchange of Ranitidine Gastrointestinal Concerns for Impurity ContainmentbrAccording to the Ministry of Food and Drug Safety, there are 269 ranitidine-based drugs that have been discontinued using ingredients containing impurities.brbr[TF BizTalk] Kim Sang-hyuns controversial ending, Gukdae Tteokbokki sales laughbrTherefore, the KFDA manufactures 269 ranitidine-based pharmaceuticals on the 26th.brbr
Labels:
라니티딘
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment